1.00 USD
▼+0.02-3.26%
盘后 1.01 -1.94%
2026-08-03
市值
$48.13M
市盈率
—
EPS
-0.88
股息率
—
52 周区间
0.86 – 4.98
成交量
394.25K
Beta
-0.74
目标价
6.50
52W 低 0.8652W 高 4.98
价格走势
公司简介
Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer’s disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The...